Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Braz. j. med. biol. res ; 48(6): 537-544, 06/2015. graf
Artículo en Inglés | LILACS | ID: lil-748218

RESUMEN

Amfepramone (diethylpropion) is an appetite-suppressant drug used for the treatment of overweight and obesity. It has been suggested that the systemic and central activity of amfepramone produces cardiovascular effects such as transient ischemic attacks and primary pulmonary hypertension. However, it is not known whether amfepramone produces immediate vascular effects when applied in vitro to rat aortic rings and, if so, what mechanisms may be involved. We analyzed the effect of amfepramone on phenylephrine-precontracted rat aortic rings with or without endothelium and the influence of inhibitors or blockers on this effect. Amfepramone produced a concentration-dependent vasorelaxation in phenylephrine-precontracted rat aortic rings that was not affected by the vehicle, atropine, 4-AP, glibenclamide, indomethacin, clotrimazole, or cycloheximide. The vasorelaxant effect of amfepramone was significantly attenuated by NG-nitro-L-arginine methyl ester (L-NAME) and tetraethylammonium (TEA), and was blocked by removal of the vascular endothelium. These results suggest that amfepramone had a direct vasorelaxant effect on phenylephrine-precontracted rat aortic rings, and that inhibition of endothelial nitric oxide synthase and the opening of Ca2+-activated K+ channels were involved in this effect.


Asunto(s)
Animales , Masculino , Acetilcolina/farmacología , Aorta Torácica/efectos de los fármacos , Depresores del Apetito/farmacología , Dietilpropión/farmacología , Vasodilatadores/farmacología , Aorta Torácica/metabolismo , Canales de Calcio/efectos de los fármacos , Canales de Calcio/metabolismo , Endotelio Vascular/efectos de los fármacos , NG-Nitroarginina Metil Éster/metabolismo , Óxido Nítrico Sintasa de Tipo III/efectos de los fármacos , Fenilefrina/farmacología , Canales de Potasio/efectos de los fármacos , Canales de Potasio/metabolismo , Ratas Wistar , Tetraetilamonio/metabolismo , Vasoconstrictores/farmacología , Vasodilatación/efectos de los fármacos
2.
Braz. j. med. biol. res ; 44(5): 438-444, May 2011. ilus
Artículo en Inglés | LILACS | ID: lil-586505

RESUMEN

The relaxant effect of the methyl ester of rosuvastatin was evaluated on aortic rings from male Wistar rats (250-300 g, 6 rats for each experimental group) with and without endothelium precontracted with 1.0 µM phenylephrine. The methyl ester presented a slightly greater potency than rosuvastatin in relaxing aortic rings, with log IC50 values of -6.88 and -6.07 M, respectively. Unlike rosuvastatin, the effect of its methyl ester was endothelium-independent. Pretreatment with 10 µM indomethacin did not inhibit, and pretreatment with 1 mM mevalonate only modestly inhibited the relaxant effect of the methyl ester. Nω-nitro-L-arginine methyl ester (L-NAME, 10 µM), the selective nitric oxide-2 (NO-2) inhibitor 1400 W (10 µM), tetraethylammonium (TEA, 10 mM), and cycloheximide (10 µM) partially inhibited the relaxant effect of the methyl ester on endothelium-denuded aortic rings. However, the combination of TEA plus either L-NAME or cycloheximide completely inhibited the relaxant effect. Inducible NO synthase (NOS-2) was only present in endothelium-denuded aortic rings, as demonstrated by immunoblot with methyl ester-treated rings. In conclusion, whereas rosuvastatin was associated with a relaxant effect dependent on endothelium and hydroxymethylglutaryl coenzyme A reductase in rat aorta, the methyl ester of rosuvastatin exhibited an endothelium-independent and only slightly hydroxymethylglutaryl coenzyme A reductase-dependent relaxant effect. Both NO produced by NOS-2 and K+ channels are involved in the relaxant effect of the methyl ester of rosuvastatin.


Asunto(s)
Animales , Masculino , Ratas , Aorta/efectos de los fármacos , Endotelio Vascular/efectos de los fármacos , Fluorobencenos/farmacología , Hidroximetilglutaril-CoA Reductasas/efectos de los fármacos , NG-Nitroarginina Metil Éster/farmacología , Pirimidinas/farmacología , Sulfonamidas/farmacología , Vasodilatación/efectos de los fármacos , Vasodilatadores/farmacología , Aorta/enzimología , Cicloheximida/farmacología , Fluorobencenos/química , Óxido Nítrico Sintasa de Tipo II/farmacología , Pirimidinas/química , Ratas Wistar , Sulfonamidas/química , Tetraetilamonio/farmacología , Vasodilatación/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA